| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C0003209> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C0021368> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C0021760> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C0026350> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C0030956> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C0032119> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C0033618> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C0039778> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C0079189> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C0086272> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C0103403> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C0876936> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C1305923> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C1698754> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C5197324> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C5200801> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33129009_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Grupo de Pesquisa em Farmacologia de Produtos Bioativos, Campus UFRJ-Macaé Professor Aloizio Teixeira Macaé, Universidade Federal do Rio de Janeiro, Rua Aloísio da Silva Gomes, 50, Macaé, RJ, Brazil. Electronic address: andrebonavita@gmail.com.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Bonavita_Andre_Gustavo>
?:doi	S0306-9877(20)33141-810.1016/j.mehy.2020.110352
?:doi	<https://research.tib.eu/covid-19/entity/S0306-9877%2820%2933141-810.1016/j.mehy.2020.110352>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Medical hypotheses
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33129009>
?:pmid	<https://research.tib.eu/covid-19/entity/33129009>
?:pmid	33129009
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.443
?:rankingScore_hIndex	75
?:title	Ac2-26 mimetic peptide of annexin A1 to treat severe COVID-19: A hypothesis.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33129009>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33129009>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all